NanoBlu Liposomal Methylene Blue is an exclusive, advanced treatment medium that combines red-light therapy with sublingual or nebulized methylene blue. Proven to reduce the effects of COVID-19, post-viral syndromes, and respiratory illnesses, it also offers neuroprotective benefits for conditions like Alzheimer’s, Parkinson’s, and stroke. NanoBlu enhances cellular oxygen consumption and supports overall health.